Blog
RSS FeedPosted by Michael Wonder on 09 Feb 2022
Angelini Pharma’s Ontozry available for patients in Scotland with drug resistant epilepsy
9 February 2022 - SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy ...
Posted by Michael Wonder on 08 Feb 2022
Cannabis-based medicine among batch of new drugs approved for use in Scotland
8 February 2022 - The medicines have been approved for use by the Scottish Medicines Consortium. ...
Posted by Michael Wonder on 07 Feb 2022
SMC - February 2022 decisions
7 February 2022 - Advice on six new medicines for use in conditions including a rare lung cancer caused by ...
Posted by Michael Wonder on 17 Jan 2022
SMC - January 2022 decisions
17 January 2022 - Advice on four new medicines for use in conditions including advanced breast cancer and non-small cell ...
Posted by Michael Wonder on 14 Dec 2021
SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation
14 December 2021 - Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland ...
Posted by Michael Wonder on 13 Dec 2021
SMC - December 2021 decisions
13 December 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has published ...
Posted by Michael Wonder on 10 Nov 2021
SMC accepts oral therapy for relapsing multiple sclerosis
10 November 2021 - Janssen has announced that the SMC have accepted Ponvory (ponesimod) within NHS Scotland, as a treatment for ...
Posted by Michael Wonder on 08 Nov 2021
SMC - November 2021 decisions
8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published ...
Posted by Michael Wonder on 13 Oct 2021
SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients
13 October 2021 - The SMC has recommended Cabometyx (cabozantinib) plus Opdivo (nivolumab) for use by via NHS Scotland for ...
Posted by Michael Wonder on 12 Oct 2021
SMC - October 2021 decisions
11 October 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland has today ...
Posted by Michael Wonder on 13 Sep 2021
SMC - September 2021 decisions
13 September 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 09 Aug 2021
Scotland backs Bavencio for bladder cancer after NICE says no
9 August 2021 - Patients with bladder cancer in Scotland will be the first in the UK to claim access ...
Posted by Michael Wonder on 09 Aug 2021
SMC - August 2021 decisions
9 August 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 14 Jul 2021
Kesimpta (ofatumumab) approved for relapsing remitting MS in Scotland
12 July 2021 - The SMC has recommended that Kesimpta can be prescribed for people with relapsing remitting multiple sclerosis who ...
Posted by Michael Wonder on 13 Jul 2021
Tecentriq, Kesimpta lead latest SMC decisions
13 July 2021 - The SMC has accepted three new medicines for use by NHS Scotland and rejected one in its ...